Daewon Pharmaceutical Market Cap

Daewon Pharmaceutical has a market cap or net worth of 244.13 billion as of February 6, 2026. Its market cap has decreased by -24.62% in one year.

Market Cap

244.13B

Enterprise Value

397.01B

Revenue

590.70B

Ranking

n/a

PE Ratio

n/a

Stock Price

11,390.00

Market Cap Chart

Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 244.13B, an increase of 1,251.76%. That is a compound annual growth rate of 11.00%.

Market Cap History

Date	Market Cap	% Change
Feb 6, 2026	244.13B	-4.69%
Dec 30, 2025	256.13B	-16.14%
Dec 30, 2024	305.43B	-7.98%
Dec 28, 2023	331.93B	-15.58%
Dec 29, 2022	393.20B	14.64%
Dec 30, 2021	343.00B	-9.91%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Korea United Pharm	279.10B
Boditech Med	275.56B
Suheung	249.07B
Chong Kun Dang Holdings	235.65B
Samjin Pharmaceuticals	235.35B
Ilyang Pharmaceutical Co.,Ltd	233.92B
Samil Pharmaceutical Co.,Ltd	229.49B
HLB Pharmaceutical	218.78B

Market Cap Rankings